John Franklin Fowler - Nov 10, 2022 Form 4 Insider Report for Kezar Life Sciences, Inc. (KZR)

Role
CEO, Director
Signature
/s/ Marc Belsky, Attorney-in-Fact
Stock symbol
KZR
Transactions as of
Nov 10, 2022
Transactions value $
$24,300
Form type
4
Date filed
11/14/2022, 07:13 AM
Previous filing
Jan 7, 2022
Next filing
Jan 10, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KZR Common Stock Options Exercise $24.3K +27K +7.36% $0.90 394K Nov 10, 2022 Direct
holding KZR Common Stock 3.75K Nov 10, 2022 By Trust
holding KZR Common Stock 38.5K Nov 10, 2022 By Montebello Holdings LLC F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KZR Employee Stock Option (Right to Buy) Options Exercise $0 -27K -32.64% $0.00 55.7K Nov 10, 2022 Common Stock 27K $0.90 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person is a member of Montebello Holdings LLC. The Reporting Person disclaims Section 16 beneficial ownership of the securities held by Montebello Holdings LLC, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for Section 16 or any other purpose.
F2 Fully vested.